Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
29,31 USD | +1,77% | +6,58% | +4,16% |
03/05 | SWISS REINSURANCE COMPANY : Barclays herhaalt het Neutraal advies | ZD |
12/04 | Transcript : Swiss Re AG - Shareholder/Analyst Call |
Omzet 2024 * | 48,32 mld. 44,85 mld. | Omzet 2025 * | 50 mld. 46,4 mld. | Marktkapitalisatie | 33,96 mld. 31,52 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 3,73 mld. 3,46 mld. | Nettowinst (verlies) 2025 * | 4,05 mld. 3,76 mld. | EV/omzet 2024 * | 0,8 x |
Nettoschuld 2024 * | 4,6 mld. 4,27 mld. | Nettoschuld 2025 * | 4,61 mld. 4,28 mld. | EV/omzet 2025 * | 0,77 x |
K/w-verhouding 2024 * |
9,23
x | K/w-verhouding 2025 * |
8,44
x | Werknemers | 14.719 |
Dividendrendement 2024 * |
6,19% | Dividendrendement 2025 * |
6,57% | Vrij verhandelbaar | 91,32% |
Recentste transcriptie over Swiss Re AG
1 dag | +1,77% | ||
1 week | +6,58% | ||
Lopende maand | +7,96% | ||
1 maand | +1,07% | ||
3 maanden | +2,16% | ||
6 maanden | +7,54% | ||
Lopend jaar | +4,16% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 55 | 01-07-16 | |
John Dacey
DFI | Director of Finance/CFO | 64 | 01-10-12 |
Velina Peneva
CIO | Chief Investment Officer | - | 01-01-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Larry Zimpleman
BRD | Director/Board Member | 72 | 20-04-18 |
Director/Board Member | 68 | 21-04-17 | |
Chairman | 63 | 21-04-17 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
10-05-24 | 29,31 | +1,77% | 17 944 |
09-05-24 | 28,8 | +0,87% | 21 140 |
08-05-24 | 28,55 | +0,82% | 17 506 |
07-05-24 | 28,32 | +1,14% | 52 043 |
06-05-24 | 28 | +1,82% | 34 707 |
uitgestelde koers OTC Markets, 10 mei 2024 om 21:45 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+4,37% | 6,75 mld. | |
+9,54% | 6,43 mld. | |
+22,00% | 6,24 mld. | |
+4,90% | 4,53 mld. | |
+12,87% | 868 mln. | |
+23,43% | 701 mln. | |
+9,29% | 507 mln. | |
+103,28% | 410 mln. | |
+7,56% | 158 mln. |
- Beurs
- Aandelen
- Koers SREN
- Koers SSREY